PharmaEssentia Corp. Statistics
PharmaEssentia Corp. (6446) Stock Statistics & Valuation Metrics
Total Valuation
PharmaEssentia Corp. has a market cap or net worth of TWD 523.94B. The enterprise value is TWD 475.32B.
- Market Cap
- TWD 523.94B
- Enterprise Value
- TWD 475.32B
Share Statistics
PharmaEssentia Corp. has 422,434,630 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 422,434,630
- Owned by Insiders
- ―
- Owned by Institutions
- 8.12%
Financial Efficiency
PharmaEssentia Corp.’s return on equity (ROE) is 0.16 and return on invested capital (ROIC) is 14.96%.
- Return on Equity (ROE)
- 0.16
- Return on Assets (ROA)
- 0.13
- Return on Invested Capital (ROIC)
- 14.96%
- Return on Capital Employed (ROCE)
- 0.15
- Revenue Per Employee
- 45.72M
- Profits Per Employee
- 14.75M
- Employee Count
- 342
- Asset Turnover
- 0.42
- Inventory Turnover
- 1.51
Valuation Ratios
The current PE Ratio of PharmaEssentia Corp. is 68.63. PharmaEssentia Corp.’s PEG ratio is 0.86.
- PE Ratio
- 68.63
- PS Ratio
- 27.20
- PB Ratio
- 15.30
- Price to FCF
- 95.05
- Price to Operating Cash Flow
- 68.00
- PEG Ratio
- 0.86
Income Statement
In the last 12 months, PharmaEssentia Corp. had revenue of 15.63B and earned 5.05B in profits. Earnings per share was 13.64.
- Revenue
- 15.63B
- Gross Profit
- 13.68B
- Operating Income
- 4.93B
- Pretax Income
- 4.98B
- Net Income
- 5.05B
- EBITDA
- 5.41B
- Earnings Per Share (EPS)
- 13.64
Cash Flow
In the last 12 months, operating cash flow was 8.28B and capital expenditures -2.34B, giving a free cash flow of 5.94B billion.
- Operating Cash Flow
- 8.28B
- Free Cash Flow
- 5.94B
- Free Cash Flow per Share
- 14.40
Dividends & Yields
PharmaEssentia Corp. pays an annual dividend of ―, resulting in a dividend yield of 0.12%
- Dividend Per Share
- ―
- Dividend Yield
- 0.12%
- Payout Ratio
- N/A
- Free Cash Flow Yield
- 1.05%
- Earnings Yield
- 1.35%
Stock Price Statistics
- Beta
- 0.64
- 52-Week Price Change
- 176.23%
- 50-Day Moving Average
- 1217.80
- 200-Day Moving Average
- 953.84
- Relative Strength Index (RSI)
- 56.45
- Average Volume (3m)
- 3.33M
Important Dates
PharmaEssentia Corp. upcoming earnings date is Nov 11, 2026, TBA (Not Confirmed).
- Last Earnings Date
- Aug 10, 2026
- Next Earnings Date
- Nov 11, 2026
- Ex-Dividend Date
- ―
Financial Position
PharmaEssentia Corp. as a current ratio of 6.20, with Debt / Equity ratio of 2.68%
- Current Ratio
- 6.20
- Quick Ratio
- 5.93
- Debt to Market Cap
- 0.00
- Net Debt to EBITDA
- -4.04
- Interest Coverage Ratio
- 193.04
Taxes
In the past 12 months, PharmaEssentia Corp. has paid -62.23M in taxes.
- Income Tax
- -62.23M
- Effective Tax Rate
- -0.01
Enterprise Valuation
PharmaEssentia Corp. EV to EBITDA ratio is 57.92, with an EV/FCF ratio of 91.45.
- EV to Sales
- 26.17
- EV to EBITDA
- 57.92
- EV to Free Cash Flow
- 91.45
- EV to Operating Cash Flow
- 65.59
Balance Sheet
PharmaEssentia Corp. has TWD 24.47B in cash and marketable securities with TWD 1.02B in debt, giving a net cash position of TWD 23.45B billion.
- Cash & Marketable Securities
- TWD 24.47B
- Total Debt
- TWD 1.02B
- Net Cash
- TWD 23.45B
- Net Cash Per Share
- TWD 55.51
- Tangible Book Value Per Share
- TWD 86.06
Margins
Gross margin is 89.83%, with operating margin of 38.41%, and net profit margin of 36.76%.
- Gross Margin
- 89.83%
- Operating Margin
- 38.41%
- Pretax Margin
- 43.18%
- Net Profit Margin
- 36.76%
- EBITDA Margin
- 45.19%
- EBIT Margin
- 43.05%
Analyst Forecast
The average price target for PharmaEssentia Corp. is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- ―
- Revenue Growth Forecast
- 64.25%
- EPS Growth Forecast
- 86.62%
